NFKB1 and hepatocellular carcinoma: It has also been shown that in mouse models of HCC, NF-κB signaling upregulates A3B, which interacts with PRC2 to inhibit H3K27me3 in order to increase CCL2 mRNA and protein levels, thereby recruiting TAMs and MDSCs to tumors [95].